KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Bristol Myers Squibb (BMY) Operating Income (2016 - 2025)

Historic Operating Income for Bristol Myers Squibb (BMY) over the last 17 years, with Q3 2025 value amounting to -$321.0 million.

  • Bristol Myers Squibb's Operating Income rose 7494.15% to -$321.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$6.6 billion, marking a year-over-year increase of 6475.69%. This contributed to the annual value of -$22.3 billion for FY2024, which is 89187.75% down from last year.
  • Latest data reveals that Bristol Myers Squibb reported Operating Income of -$321.0 million as of Q3 2025, which was up 7494.15% from -$1.6 billion recorded in Q2 2025.
  • In the past 5 years, Bristol Myers Squibb's Operating Income ranged from a high of $204.0 million in Q1 2023 and a low of -$14.4 billion during Q1 2024
  • Over the past 5 years, Bristol Myers Squibb's median Operating Income value was -$762.0 million (recorded in 2022), while the average stood at -$1.6 billion.
  • Its Operating Income has fluctuated over the past 5 years, first surged by 12602.04% in 2023, then crashed by 718235.29% in 2024.
  • Quarter analysis of 5 years shows Bristol Myers Squibb's Operating Income stood at -$498.0 million in 2021, then plummeted by 47.39% to -$734.0 million in 2022, then plummeted by 45.91% to -$1.1 billion in 2023, then tumbled by 332.96% to -$4.6 billion in 2024, then surged by 93.08% to -$321.0 million in 2025.
  • Its last three reported values are -$321.0 million in Q3 2025, -$1.6 billion for Q2 2025, and -$62.0 million during Q1 2025.